Address	Yalelaan 62 Utrecht Utrecht 3584 CH Netherlands
Employees	-
Website	http://www.merus.nl
Updated	07/08/2019
Merus NV is a clinical-stage immune-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg on June 16, 2003 and is headquartered in Utrecht, Netherlands.